NO20073767L - Produkt inneholdende prostaglandin F2-alfa-derivat - Google Patents

Produkt inneholdende prostaglandin F2-alfa-derivat

Info

Publication number
NO20073767L
NO20073767L NO20073767A NO20073767A NO20073767L NO 20073767 L NO20073767 L NO 20073767L NO 20073767 A NO20073767 A NO 20073767A NO 20073767 A NO20073767 A NO 20073767A NO 20073767 L NO20073767 L NO 20073767L
Authority
NO
Norway
Prior art keywords
prostaglandin
derivative
product containing
propylene
molecule
Prior art date
Application number
NO20073767A
Other languages
English (en)
Other versions
NO338832B1 (no
Inventor
Takehiro Kado
Ajio Kimura
Hiroshi Yamada
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO20073767L publication Critical patent/NO20073767L/no
Publication of NO338832B1 publication Critical patent/NO338832B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/10—Homopolymers or copolymers of propene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/10—Homopolymers or copolymers of propene
    • C08L23/14—Copolymers of propene
    • C08L23/142—Copolymers of propene at least partially crystalline copolymers of propene with other olefins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Oppfinnelsen tilveiebringer en harpiksfremstilt beholder som muliggjør langtidsstabil konservering av vandige flytende preparater inneholdende prostaglandin F2? derivater med fluoratomer i molekylet. Et vandig flytende preparat inneholdende et prostaglandin F2? derivat med et fluoratom i molekylet er beskyttet mot nedsettelse av prostaglandin F2? derivatinnholdet ved å holde preparatet i en beholder fremstilt av propylen/etylen kopolymer med et propylen/etylen forhold på fra 94,0/6,0 til 99,5/0,5.
NO20073767A 2004-12-24 2007-07-19 Prostaglandin F2-alpha-derivatholdig produkt og fremgangsmåte for inhibering av en minsking i innholdet av et prostaglandin F2-alpha-derivat med minst et kloratom i sitt molekyl i et vandig flytende preparat NO338832B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004374009 2004-12-24
PCT/JP2005/023704 WO2006068266A1 (ja) 2004-12-24 2005-12-26 プロスタグランジンＦ２ａ誘導体含有製品

Publications (2)

Publication Number Publication Date
NO20073767L true NO20073767L (no) 2007-09-14
NO338832B1 NO338832B1 (no) 2016-10-24

Family

ID=36601858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073767A NO338832B1 (no) 2004-12-24 2007-07-19 Prostaglandin F2-alpha-derivatholdig produkt og fremgangsmåte for inhibering av en minsking i innholdet av et prostaglandin F2-alpha-derivat med minst et kloratom i sitt molekyl i et vandig flytende preparat

Country Status (14)

Country Link
US (1) US20070244196A1 (no)
EP (1) EP1829545B1 (no)
KR (1) KR101283874B1 (no)
CN (1) CN101175496A (no)
AT (1) ATE555792T1 (no)
CA (1) CA2592474C (no)
DK (1) DK1829545T3 (no)
ES (1) ES2386148T3 (no)
NO (1) NO338832B1 (no)
PL (1) PL1829545T3 (no)
PT (1) PT1829545E (no)
RU (1) RU2391983C2 (no)
SI (1) SI1829545T1 (no)
WO (1) WO2006068266A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
CN106929477B (zh) * 2017-03-20 2020-01-10 江南大学 一株抗前列腺素F2α的特异性单克隆抗体杂交瘤细胞株WXX-2及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2886035A (en) * 1955-07-29 1959-05-12 Cutter Lab Venoclysis apparatus
US2985920A (en) * 1958-03-26 1961-05-30 Seiberling Rubber Co Method of making a cored heel
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
JPH06285135A (ja) * 1993-03-31 1994-10-11 Kyoraku Co Ltd 薬液用プラスチック容器
US5486540A (en) * 1993-10-28 1996-01-23 Allergan, Inc. Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
BR9906597A (pt) * 1998-07-14 2000-07-18 Alcon Lab Inc Produto de prostaglandina
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
DK1321144T3 (da) * 2000-09-13 2011-03-07 Santen Pharmaceutical Co Ltd Øjendråber
JP3876355B2 (ja) * 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
WO2002022106A2 (en) * 2000-09-14 2002-03-21 Novartis Ag Stable ophthalmic preparation
TW586946B (en) * 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
JP2003138074A (ja) * 2001-10-30 2003-05-14 Japan Polychem Corp 医療用延伸ブロー容器
ATE450264T1 (de) * 2003-07-31 2009-12-15 Santen Pharmaceutical Co Ltd Prostaglandin enthaltendes produkt
US20050049311A1 (en) * 2003-09-03 2005-03-03 Pharmacia & Upjohn Company Medicinal products comprising prostaglandin compositions and methods of packaging such compositions

Also Published As

Publication number Publication date
WO2006068266A1 (ja) 2006-06-29
DK1829545T3 (da) 2012-07-23
ES2386148T3 (es) 2012-08-10
CA2592474C (en) 2013-08-13
ATE555792T1 (de) 2012-05-15
EP1829545A4 (en) 2009-07-22
PT1829545E (pt) 2012-05-21
RU2007128318A (ru) 2009-01-27
PL1829545T3 (pl) 2012-09-28
SI1829545T1 (sl) 2012-08-31
RU2391983C2 (ru) 2010-06-20
KR101283874B1 (ko) 2013-07-08
NO338832B1 (no) 2016-10-24
EP1829545B1 (en) 2012-05-02
CN101175496A (zh) 2008-05-07
KR20070093997A (ko) 2007-09-19
US20070244196A1 (en) 2007-10-18
EP1829545A1 (en) 2007-09-05
CA2592474A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
NO20073353L (no) Produkt som har prostaglandin som har fluoratom i molekyl
BRPI0809891C8 (pt) dispensador, produto e composições de espuma higienizante
NL350088I2 (nl) Fluopyram en prothioconazool
BRPI0407890A (pt) kit formador de espuma contendo um dosador formador de espuma e uma composição com alto teor de tensoativo
MXPA05009195A (es) Un kit de limpieza y/o un kit para lavado de vajilla que contienen un despachador generador de espuma y una composicion limpiadora y/o para el lavado de vajilla.
NO20075064L (no) Skummingssammensetninger med hoyt alkoholinnhold og med silikonbaserte overflateaktive midler
WO2009035004A1 (ja) 置換イソキサゾリン化合物および有害生物防除剤
WO2008115098A3 (fr) 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation
GB201201744D0 (en) Novel compounds
WO2009075142A1 (ja) 殺菌清浄剤組成物
NO20073767L (no) Produkt inneholdende prostaglandin F2-alfa-derivat
NO20080725L (no) Konserverende sammensetning for oftalmisk anvendelse
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
NO922063L (no) Lineaerviskoelastisk, vandig, flytende maskinoppvaskmiddelblanding med forbedret klorstabilitet
ATE399546T1 (de) Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1
NO20072078L (no) Indolderivater som inhibitorer av loselig adenylsyklase
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
FI923841A0 (fi) Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
US20210238201A1 (en) Antimicrobial compounds and compositions
NO20091491L (no) Fluorerte catharantinderivater, deres fremstilling og deres anvendelse som vincadimore alkaloidforlopere
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner
ATE374751T1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
CN119013366A (zh) 液体组合物
GB0114699D0 (en) Organic compounds
Wohlfarth Refractive index of the mixture (1) ethyl chloroacetate;(2) methoxybenzene: Data extract from Landolt-Börnstein III/47: Optical Constants

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees